The genetic and epigenetic landscape for CNS drug discovery targeting cross-diagnostic behavioral domains

被引：4
|
作者：
de Mooij-van Malsen, Annetrude [1 ,2 ]
Pjetri, Eneda [1 ,3 ]
Kas, Martien J. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands
[2] CAU Kiel, Inst Physiol, Kiel, Germany
[3] UNC Chapel Hill Nutr Res Inst, Kannapolis, NC 28081 USA
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 2015年 / 753卷
关键词：
Behavior; Psychiatry; Drug targets; Endophenotypes; Mouse; Human; MOUSE AVOIDANCE-BEHAVIOR; GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; EATING-DISORDERS; MOOD DISORDER; SCHIZOPHRENIA; MICE; SUSCEPTIBILITY; CONSORTIUM; SEQUENCE;
D O I：
10.1016/j.ejphar.2014.07.043
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Animal studies play a central role in the identification and testing of novel drugs for CNS disorders. In his longstanding career, Berend Olivier has significantly contributed to CNS drug discovery by applying and supporting novel views and methodologies in the fields of behavioral neuroscience, pharmacology, and (epi-) genetics. Here we review and put forward some of these integrated approaches that have led to a productive collaboration and new insights into the genetic and epigenetic regulation of neurobehavioural traits related to psychiatric disorders. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码：135 / 139
页数：5
相关论文
共 34 条
  • [1] Exploring the epigenetic drug discovery landscape
    Prachayasittikul, Veda
    Prathipati, Philip
    Pratiwi, Reny
    Phanus-umporn, Chuleeporn
    Malik, Aijaz Ahmad
    Schaduangrat, Nalini
    Seenprachawong, Kanokwan
    Wongchitrat, Prapimpun
    Supokawej, Aungkura
    Prachayasittikul, Virapong
    Wikberg, Jarl E. S.
    Nantasenamat, Chanin
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (04) : 345 - 362
  • [2] Targeting epigenetic enzymes for drug discovery
    Copeland, Robert A.
    Olhava, Edward J.
    Scott, Margaret Porter
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (04) : 505 - 510
  • [3] Epigenetic Drug Discovery: Targeting DNA Methyltransferases
    Foulks, Jason M.
    Parnell, K. Mark
    Nix, Rebecca N.
    Chau, Suzanna
    Swierczek, Krzysztof
    Saunders, Michael
    Wright, Kevin
    Hendrickson, Thomas F.
    Ho, Koc-Kan
    McCullar, Michael V.
    Kanner, Steven B.
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (01) : 2 - 17
  • [4] Targeting Epigenetic Enzymes for Drug Discovery and Development
    Bryant K.
    Genetic Engineering and Biotechnology News, 2019, 39 (06): : 50 - 52
  • [5] Epigenetic drug discovery by artificial genetic switches
    Bando T.
    Sugiyama H.
    Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry, 2020, 78 (05): : 476 - 484
  • [6] Epigenetic Drug Discovery by Artificial Genetic Switches
    Bando, Toshikazu
    Sugiyama, Hiroshi
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2020, 78 (05) : 476 - 484
  • [7] Computational Methods for Epigenetic Drug Discovery: A Focus on Activity Landscape Modeling
    Jesus Naveja, J.
    Iluhi Oviedo-Osornio, C.
    Medina-Franco, Jose L.
    COMPUTATIONAL MOLECULAR MODELLING IN STRUCTURAL BIOLOGY, 2018, 113 : 65 - 83
  • [8] Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome
    Chen, Yi
    Wang, Guiquan
    Chen, Jingqiao
    Wang, Congying
    Dong, Xi
    Chang, Hsun-Ming
    Yuan, Shuai
    Zhao, Yue
    Mu, Liangshan
    ENDOCRINE REVIEWS, 2024, 45 (04) : 437 - 459
  • [9] Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery
    Li, Yang
    Yang, Gaoxia
    Yang, Chengcan
    Tang, Pan
    Chen, Juncheng
    Zhang, Jifa
    Liu, Jie
    Ouyang, Liang
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (16) : 11798 - 11815
  • [10] Drug Discovery, Diagnostic, and therapeutic trends on Mpox: A patent landscape
    Sharma, Rohit
    Sharma, Ruchi
    Singla, Rajeev K.
    CURRENT RESEARCH IN BIOTECHNOLOGY, 2024, 7
1234